FDA approves pasatru (garetosmab-grts) for FOP adults
Regeneron Pharmaceuticals (REGN) says the FDA approves pasatru (garetosmab-grts) for adults with fibrodysplasia ossificans progressiva.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.